ESG Report

Our annual ESG reporting covers BeiGene’s performance in the latest fiscal year and aligns with BeiGene’s financial reporting. Please find our most recent updates in the 2022 ESG Report. Previous reports are available here.

Change propels new ways of thinking, operating, and innovating. Change Is the Cure, BeiGene’s ESG strategy, frames our approach for helping change the world for the better. It begins with our commitment to advancing global health by making innovative medicines more accessible to more people around the world.

John V. Oyler, Co-Founder, Chairman, and CEO
April 2023

Change Is the Cure outlines our five ESG focus areas and strategic priorities, and we have committed to ambitious long-term goals in each of these areas. These goals are also intentionally aligned with the UN SDGs, specifically three SDGs.